PetMed Express (PETS) Stock Price, News & Analysis

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings or view top-rated stocks.

2 brokerages have issued 1 year price targets for PetMed Express' shares. Their PETS share price targets range from $6.50 to $20.00. On average, they anticipate the company's share price to reach $13.25 in the next twelve months. This suggests a possible upside of 214.0% from the stock's current price.
View analysts price targets for PETS or view top-rated stocks among Wall Street analysts.

PetMed Express' stock was trading at $7.56 at the start of the year. Since then, PETS shares have decreased by 44.2% and is now trading at $4.22.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our PETS earnings forecast.

PetMed Express, Inc. (NASDAQ:PETS) issued its quarterly earnings results on Monday, October, 30th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.18 by $0.09. The firm had revenue of $71 million for the quarter, compared to analyst estimates of $77.13 million. PetMed Express had a positive trailing twelve-month return on equity of 0.93% and a negative net margin of 2.25%. During the same period in the previous year, the firm posted $0.13 EPS.

PetMed Express declared a quarterly dividend on Monday, July 31st. Investors of record on Monday, August 14th will be paid a dividend of $0.30 per share on Friday, August 18th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 28.44%. The ex-dividend date of this dividend is Friday, August 11th.
Read our dividend analysis for PETS.

ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Formidable ETF (FORH).Global X E-Commerce ETF (EBIZ).

PetMed Express updated its third quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $65.3 million-$65.3 million, compared to the consensus revenue estimate of $68.0 million.

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional investors include Profit Investment Management LLC (0.46%). Insiders that own company stock include Bruce S Rosenbloom, Christine Chambers, Gian Fulgoni and Mathew N Hulett.
View institutional ownership trends.

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.